Sarah Diermeier

13PUBLICATIONS
58CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 24, 2024
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function.

Manojit M Swamynathan, Shan Kuang, Kaitlin E Watrud

|Oct 10, 2024
Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics.

Holly R Pinkney, Cody R Ross, Timothy O Hodgson

|Jul 27, 2024
The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma.

William J H Davis, Catherine J Drummond, Sarah Diermeier

|Jan 11, 2024
FABP5 Inhibition against <i>PTEN</i>-Mutant Therapy Resistant Prostate Cancer.

Manojit M Swamynathan, Grinu Mathew, Andrei Aziz

|Nov 13, 2021
Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation.

Prithi Raguraman, Akilandeswari Ashwini Balachandran, Suxiang Chen

|Oct 23, 2021
Anti-Proliferative, Anti-Angiogenic and Safety Profiles of Novel HDAC Inhibitors for the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Zohaib Rana, Sarah Diermeier, Fearghal P Walsh

Pageof 3

Frequent Collaborators

3 joint publications

Holly R Pinkney

2 joint publications

Lloyd C Trotman

2 joint publications

Grinu Mathew

2 joint publications

Manojit M Swamynathan